{"id":"W2909359012","doi":"10.1016/j.carrev.2019.01.012","title":"CD34+ Cell Therapy for No-Option Refractory Disabling Angina: Time for FDA Approval?","year":2019,"lang":"en","type":"letter","venue":"Cardiovascular revascularization medicine","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Angina; Cardiology; Canadian Cardiovascular Society; Internal medicine; Tolerability; Revascularization; Adverse effect; TIMI; Unstable angina; Myocardial infarction; Percutaneous coronary intervention","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003172567,0.0005277975,0.001253355,0.0006517706,0.003007304,0.004606512,0.00146803,0.0562459,0.0120961],"category_scores_gemma":[0.01510303,0.0004613952,0.001445732,0.0005053188,0.002283867,0.003568124,0.001283633,0.02614607,0.006785023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004283094,"about_ca_system_score_gemma":0.005797728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005724099,"about_ca_topic_score_gemma":0.01698397,"domain_scores_codex":[0.9970154,0.000821502,0.0003621891,0.000305526,0.0009426321,0.0005529014],"domain_scores_gemma":[0.9931995,0.003725567,0.0004669948,0.0001707296,0.001104445,0.001332767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001332213,0.00008261042,0.0006674796,0.00006825797,0.00002063005,0.002456094,0.0001035328,0.00009930348,0.0004952082,0.009613495,0.9596907,0.02656951],"study_design_scores_gemma":[0.0002326269,0.0001489194,0.001018428,0.0005241267,0.0000393932,0.00193568,0.0003825314,0.0006168659,0.0002916409,0.01795105,0.9767911,0.00006760731],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0004932091,0.001901561,0.0001456113,0.9829995,0.007014676,0.00001062128,0.00005780486,0.00002788279,0.007349154],"genre_scores_gemma":[0.008270827,0.002261025,0.0006034588,0.9470054,0.02651376,0.00003599157,0.00006013731,0.00003356443,0.01521588],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.0562459,"threshold_uncertainty_score":0.04046553,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02359550798920124,"score_gpt":0.266304420104707,"score_spread":0.2427089121155058,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}